(2E)-1-(3-bromophenyl)-3-(3-fluorophenyl)prop-2-en-1-one, 95.0%, 10g

(Trifluoromethyl)cyclohexane>98.0%(GC)25g

4,4-Di(9H-carbazol-9-yl)-1,1-biphenyl, 97.0%, 10g

DL-2,3-Diphenylsuccinic acid anhydride, 98.0%, 2g

2,2-Difluoroethanamine hydrochloride, 98.0%, 100g

2-(4-Bromopyrazol-1-yl)ethanol, 95.0%, 250mg

Colonna capillare per GC ROTI®Cap-1701 MS, 60 m, 0.32 mm, 0.50 µm, 1 Pezzo(i)

1-(4-BROMOPHENYL)-2,2-DIFLUOROETHANONE, 95.0%, 50mg

2-Bromo-4-fluoro-4'-methyl-1,1'-biphenyl, 98%, 5g

5-(3,5-Dimethoxyphenyl)-3-oxopentanenitrile, 98%, 100mg

2-(piperidin-4-yl)-4,5,6,7-tetrahydro-1H-benzo[d]imidazole dihydrochloride, 95.0%, 500mg

4-CHLOROMETHYL-4-HYDROXYMETHYL-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER, 95.0%, 1g

Quinoxaline 1,4-Dioxide>95.0%(HPLC)(T)1g